Orlando, FL — May 28, 2015 — Vasculitis can cause people to suffer from a variety of symptoms such as headache, fever, weight loss, fatigue, night sweats, rash and nerve problems. However, it seems that sufferers are getting close to having a helpful treatment.
A study revealed that a new vasculitis treatment may be as good as standard therapy. This condition is uncommon and is characterized by the inflammation of blood vessels. Treatment is often focused on decreasing blood vessel inflammation and enhancing the function of the organs affected.
The New England Journal of Medicine published a study that found the biologic drug rituximab works well in controlling a type of vasculitis. The treatment involved four weekly infusions of the drug, which was believed to be equivalent to an 18-month daily intake of immunosuppressive pills.
Ulrich Specks, M.D., chair of the division of pulmonary and critical care medicine at the Mayo Clinic, believes that it’s a game changer. He added that having a good alternative to traditional medicine would be very good news.
According to The Arthritis Foundation, vasculitis is an autoimmune disease that takes place when the body mistakenly considers the blood vessels as foreign invaders, and thus attacks them. This causes inflammation and eventually a narrowing of the vessels. Severe cases of vasculitis often make patients suffer from organ damage or even death. Although there are many types of vasculitis, the one examined by the study is known as the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
“There are times when vasculitis is successfully treated. However, it can recur and never really goes away. There are even times when it requires long-term, ongoing treatment,” said VitaBreeze Supplements spokesperson, Michelle O’Sullivan.
Rituximab is a biologic drug that works by depleting B-cells, which are a type of white blood cell. It is often used as a treatment for rheumatoid arthritis, some blood cancers and other conditions. The Food and Drug Administraion (or FDA) has approved rituximad in 2011 as the first new treatment for AAV.
Many rheumatoid arthritis patients use drugs such as Rituximab, but there are also those who use natural supplements such as curcumin. Vasculitis and arthritis have things in common and one is inflammation. However, for many arthritis patients inflammation can be properly addressed with the use of treatments such as curcumin.
Curcumin, which is a key ingredient of turmeric, contains antioxidant, anti-inflammatory and anti-bacterial properties. It is believed to be effective in helping patients achieve pain relief and improved mobility (http://www.amazon.com/Turmeric-Curcumin-Complex-BioPerine-Bio-availability/dp/B00JA4TLTI/).
About VitaBreeze
VitaBreeze is a nutraceutical brand that manufactures high-quality natural supplements to help people live a healthy, enjoyable and longer life. All of the company’s products are manufactured in the United States using the finest quality ingredients that have been carefully selected, tested and crafted into the firm’s winning formulas. Visit http://www.VitaBreeze.com to learn more.
MEDIA CONTACT INFORMATION
Benjamin Lasance
(407) 545-2239
[email protected]
Website: www.VitaBreeze.com
